A rapid, sensitive, multiplexed assay for detection of viral nucleic acids using the FlowMetrix system.

Sensitive assays for viral nucleic acids are important tools for the accurate diagnosis and treatment of viral diseases. Unlike serological methods, viral load analysis provides quantitative information about viral replication. Studies have shown that viral load is a powerful predictor of disease progression in both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections (1)(2) . Additionally, monitoring viral load is a proven method for assessing the effects of antiviral treatments for both HIV and HCV infections (3)(4)(5)(6) . Recently, the need for simultaneous viral load determinations of different viruses within a single individual has been established. Numerous studies indicate synergistic effects of co-infection with multiple viruses. For example, higher HCV titers have been reported in individuals co-infected with HIV (7) . Likewise, herpes simplex virus (HSV) infections can be particularly severe in individuals with HIV-compromised immune systems (8) . This report describes a novel method for the detection and quantitation of viral nucleic acids in a rapid, multiplexed format. This method is based on fluorescent detection using the FlowMetrix analysis system. The FlowMetrix system is a computer-enhanced flow cytometer that uses microspheres dyed with multiple fluorescent colors (9) . The microspheres are …

[1]  K. Chayama,et al.  Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C , 1991, Hepatology.

[2]  M J Benecky,et al.  Detection of hepatitis B surface antigen in whole blood by coupled particle light scattering (Copalis). , 1997, Clinical chemistry.

[3]  J. Kappes,et al.  Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared. , 1995, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

[4]  O. Yokosuka,et al.  Quantification of hepatitis C virus by competitive reverse transcription—polymerase chain reaction: Increase of the virus in advanced liver disease , 1993, Hepatology.

[5]  E. Diamandis,et al.  Multianalyte immunoassay based on spatially distinct fluorescent areas quantified by laser-excited solid-phase time-resolved fluorometry. , 1992, Clinical chemistry.

[6]  M. Urdea,et al.  Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections , 1993, Journal of clinical microbiology.

[7]  L. Corey,et al.  Herpesvirus infections in persons infected with human immunodeficiency virus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  T. Myers,et al.  Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay , 1993, Journal of clinical microbiology.

[9]  K. Harada,et al.  Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects , 1996, Science.

[10]  J. Hoofnagle,et al.  A pilot study of ribavirin therapy for chronic hepatitis C , 1992, Hepatology.

[11]  R J Fulton,et al.  Advanced multiplexed analysis with the FlowMetrix system. , 1997, Clinical chemistry.

[12]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[13]  Meei-Li W Huang,et al.  Coamplified positive control detects inhibition of polymerase chain reactions , 1992, Journal of clinical microbiology.

[14]  References , 1971 .

[15]  R. Schooley Correlation between viral load measurements and outcome in clinical trials of antiviral drugs. , 1995, AIDS.

[16]  E. Tan,et al.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. , 1982, Advances in immunology.